Skip to main content

A Randomized Trial of Postoperative Five-Versus Three-Drug Chemotherapy After Mastectomy: A Cancer and Leukemia Group B (CALGB) Study

  • Chapter
Adjuvant Therapies of Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 80))

Summary

The Cancer and Leukemia Group B (CALB) has conducted a randomized study of adjuvant chemotherapy in patients with breast cancer who have involved axillary nodes at the time of mastectomy. Five-drug treatment (CMFVP) was compared with three-drug treatment (CMF). For patients with more than three involved nodes, the CMFVP regimen produced a significantly prolonged disease-free survival in comparison to the CMF regimen.

This work was supported by grants CA 04457 and CA 16118 from the Division of Cancer Treatment, National Cancer Institute, Bethesda, MD (USA)

The authors thank Mrs. Barbara B. Shepherd for her valuable assistance in the preparation of this manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonadonna G, Valagussa P (to be published) Adjuvant therapy of primary breast cancer. In: Carter SK, Glatstein E, Livingston RB (eds) Principles of cancer treatment. McGraw-Hill, New York

    Google Scholar 

  2. Bonadonna G, Brusamolino E, Valagussa P, et al. (1976) Combination chemotherapy as an, adjuvant treatment in operable breast cancer. N Engl J Med 294:405—410

    Article  PubMed  CAS  Google Scholar 

  3. Bonadonna G, Valagussa P, Rossi A, et al. (1978) Are surgical adjuvant trials altering the course of breast cancer? Semin Oncol 5:450–464

    PubMed  CAS  Google Scholar 

  4. Cooper RG, Holland JF, Glidewell O (1979) Adjuvant chemotherapy of breast cancer. Cancer 44:793–798

    Article  PubMed  CAS  Google Scholar 

  5. Tormey D, Falkson G, Weiss R, Perloff M, Glidewell I, Holland JF (1979) Postoperative chemotherapy with/without immunotherapy for mammary carcinoma: A preliminary report. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer II. Grune & Stratton, New York, pp 253–260

    Google Scholar 

  6. Weiss DW (1976) MER and other mycobacterial fractions in the immunotherapy of cancer. Med Clin North Am 60:473–497

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Weiss, R.B. et al. (1982). A Randomized Trial of Postoperative Five-Versus Three-Drug Chemotherapy After Mastectomy: A Cancer and Leukemia Group B (CALGB) Study. In: Mathé, G., Bonadonna, G., Salmon, S. (eds) Adjuvant Therapies of Cancer. Recent Results in Cancer Research, vol 80. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81685-7_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81685-7_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81687-1

  • Online ISBN: 978-3-642-81685-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics